Insulin Degludec

Common brands: Tresiba, Humalog Kwikpen, Humalog Junior Kwikpen, Humalog Mix75/25, Humalog

Top reporter: Novo Nordisk

Insulin Analog [EPC]GLP-1 Receptor Agonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]HMG-CoA Reductase Inhibitor [EPC]Loop Diuretic [EPC]
22,571
Total Reports
11,400
Serious Reports
1,236
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.48%)

Patient Demographics

Male
9,250
Female
12,118

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Insulin Degludec.

# Reaction Reports % of Total
1 BLOOD GLUCOSE INCREASED 3,670
15.7%
2 NAUSEA 1,420
6.1%
3 BLOOD GLUCOSE DECREASED 1,275
5.5%
4 DRUG INEFFECTIVE 988
4.2%
5 OFF LABEL USE 949
4.1%
6 VOMITING 936
4.0%
7 DIARRHOEA 923
4.0%
8 HYPOGLYCAEMIA 913
3.9%
9 FATIGUE 881
3.8%
10 DYSPNOEA 779
3.3%
11 FALL 687
2.9%
12 DIZZINESS 668
2.9%
13 CONSTIPATION 663
2.8%
14 HEADACHE 649
2.8%
15 MALAISE 557
2.4%
16 GLYCOSYLATED HAEMOGLOBIN INCREASED 555
2.4%
17 WEIGHT INCREASED 553
2.4%
18 PAIN 550
2.4%
19 ABDOMINAL PAIN 543
2.3%
20 INJECTION SITE PAIN 503
2.2%
21 WEIGHT DECREASED 498
2.1%
22 VISUAL IMPAIRMENT 484
2.1%
23 ASTHENIA 474
2.0%
24 INCORRECT DOSE ADMINISTERED 473
2.0%
25 DEATH 471
2.0%
26 CONDITION AGGRAVATED 468
2.0%
27 DECREASED APPETITE 466
2.0%
28 STRESS 457
2.0%
29 PRODUCT DOSE OMISSION ISSUE 442
1.9%
30 ABDOMINAL DISTENSION 440
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.